4011 POSTER Results of a phase 3, randomized study of patients with advanced renal cell carcinoma (RCC) and poor prognostic features treated with temsirolimus, interferon-a or the combination of temsirolimus + interferon-a

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Ejc Supplements

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1359-6349(07)71079-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials

  2016cites this paper
• Clinical trial experience with temsirolimus in patients with advanced renal cell carcinoma.

  2009cites this paper
• Book Review: Essentials of pharmacoeconomics

  2009cites this paper
• Essentials of pharmacoeconomics

  2009cites this paper
• Current algorithms and prognostic factors in the treatment of metastatic renal cell carcinoma.

  2008cites this paper
• Essentials of Pharmacoeconomics

  2008cites this paper